Our goal at Collidion Inc. is to create immediate to long-term value for our partners through the repositioning of drugs and medical devices that would otherwise remain undervalued.
Collidion is a healthcare company with a focus on external innovation by covering various segments of the international healthcare market. The company intends to build a strong and transformative portfolio of healthcare assets through;
- Acquisition or licensing both drugs and devices at various stages of development
- Development of such assets into stand-alone subsidiaries
- Provide broad-spectrum operational, regulatory and management support
- Participate in subsequent funding, partnering and merger and acquisition activities
Our key area of interest is to partner and develop licensed technologies from external companies to help combat antibiotic resistance in the healthcare setting.
Collidion's Core Areas of Focus
Combat Antibiotic Resistance
Specific Drugs to Eradicate Biofilms
Delivery Systems for Systemic Use
Delivery Systems for Topical Use